Michael del Priore
Keine laufenden Positionen mehr
Profil
Derzeit hat Michael Del Priore die Position des Chief Information Officer bei Diversey Holdings Ltd. (Cayman Islands). Zuvor war er Chief Information Officer bei Church & Dwight Co, Inc. und Director-Information Systems bei Philip Morris USA, Inc. sowie Chief Information Officer & Senior Vice President bei Catalent Pharma Solutions, Inc. und Vice President-Global Commercial IT Operations bei Hoffmann-La Roche, Inc. Er erhielt einen Undergraduate-Abschluss von der State University of New York und einen MBA von der Pace University.
Ehemalige bekannte Positionen von Michael del Priore
Unternehmen | Position | Ende |
---|---|---|
DIVERSEY HOLDINGS, LTD. | Chief Tech/Sci/R&D Officer | 05.07.2023 |
Philip Morris USA, Inc.
Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Chief Tech/Sci/R&D Officer | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Chief Tech/Sci/R&D Officer | - |
CHURCH & DWIGHT CO., INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Michael del Priore
Pace University | Masters Business Admin |
The State University of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CHURCH & DWIGHT CO., INC. | Consumer Non-Durables |
Private Unternehmen | 4 |
---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Philip Morris USA, Inc.
Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Consumer Non-Durables |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Diversey Holdings Ltd. (Cayman Islands)
Diversey Holdings Ltd. (Cayman Islands) Household/Personal CareConsumer Non-Durables Diversey Holdings Ltd. engages in the provision of hygiene, infection prevention, and cleaning solutions. It operates through the Institutional and Food and Beverage segments. The Institutional segment offers solutions to enhance cleanliness, safety, environmental sustainability, and efficiency for its customers. The Food and Beverage segment includes products to maximize the hygiene, safety, and efficiency of customer's production and cleaning processes while minimizing impact on the natural resources it consume. Its products and services include infection prevention, floor and building care chemicals, laundry, dosing and dispensing equipment, engineering and equipment solutions,, and water treatment. The company was founded on November 3, 2020, and is headquartered in Fort Mill, SC. | Consumer Non-Durables |